Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Consumption of sweetened, dried cranberries may reduce urinary tract infection incidence in susceptible women--a modified observational study.

Burleigh AE, Benck SM, McAchran SE, Reed JD, Krueger CG, Hopkins WJ.

Nutr J. 2013 Oct 18;12(1):139. doi: 10.1186/1475-2891-12-139.

2.

Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice.

Suhs KA, Marthaler BR, Welch RA, Hopkins WJ.

MBio. 2011 May 31;2(3):e00094-11. doi: 10.1128/mBio.00094-11. Print 2011.

3.

Quantitative trait loci associated with susceptibility to bladder and kidney infections induced by Escherichia coli in female C3H/HeJ mice.

Hopkins WJ, Elkahwaji J, Kendziorski C, Moser AR, Briggs PM, Suhs KA.

J Infect Dis. 2009 Feb 1;199(3):355-61. doi: 10.1086/595987.

4.

Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.

Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT.

J Urol. 2007 Apr;177(4):1349-53; quiz 1591.

PMID:
17382730
5.

Acute acrolein-induced cystitis in mice.

Bjorling DE, Elkahwaji JE, Bushman W, Janda LM, Boldon K, Hopkins WJ, Wang ZY.

BJU Int. 2007 Jun;99(6):1523-9. Epub 2007 Mar 6.

6.

Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis.

Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W.

Prostate. 2007 Jan 1;67(1):14-21.

PMID:
17075821
7.

Mouse model for acute bacterial prostatitis in genetically distinct inbred strains.

Elkahwaji JE, Ott CJ, Janda LM, Hopkins WJ.

Urology. 2005 Oct;66(4):883-7.

PMID:
16230175
8.

Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.

Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE.

J Urol. 2003 Sep;170(3):867-9.

PMID:
12913718
9.

Inheritance of susceptibility to induced Escherichia coli bladder and kidney infections in female C3H/HeJ mice.

Hopkins WJ, Elkahwaji JE, Heisey DM, Ott CJ.

J Infect Dis. 2003 Feb 1;187(3):418-23. Epub 2003 Jan 24.

PMID:
12552425
10.

Vaccine Development for the Prevention of Urinary Tract Infections.

Hopkins WJ, Uehling DT.

Curr Infect Dis Rep. 2002 Dec;4(6):509-513.

PMID:
12433326
12.

Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial.

Uehling DT, Hopkins WJ, Beierle LM, Kryger JV, Heisey DM.

J Infect Dis. 2001 Mar 1;183 Suppl 1:S81-3. No abstract available.

PMID:
11171022
13.

The urinary tract response to entry of pathogens.

Uehling DT, Johnson DB, Hopkins WJ.

World J Urol. 1999 Dec;17(6):351-8. Review.

PMID:
10654365
14.

Evaluation of a familial predisposition to recurrent urinary tract infections in women.

Hopkins WJ, Uehling DT, Wargowski DS.

Am J Med Genet. 1999 Apr 23;83(5):422-4. No abstract available.

PMID:
10232756
16.

Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.

Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT.

Infect Immun. 1998 Jun;66(6):2798-802.

18.
19.

Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.

Uehling DT, Hopkins WJ, Balish E, Xing Y, Heisey DM.

J Urol. 1997 Jun;157(6):2049-52.

PMID:
9146577
20.

Supplemental Content

Loading ...
Support Center